PROCEPT BioRobotics PRCT Stock
PROCEPT BioRobotics Price Chart
PROCEPT BioRobotics PRCT Financial and Trading Overview
| PROCEPT BioRobotics stock price | 20.6 USD |
| Previous Close | 21.06 USD |
| Open | 21.26 USD |
| Bid | 15.36 USD x 200 |
| Ask | 25.8 USD x 200 |
| Day's Range | 19.95 - 21.47 USD |
| 52 Week Range | 19.35 - 62.17 USD |
| Volume | 455.83K USD |
| Avg. Volume | 1.48M USD |
| Market Cap | 1.14B USD |
| Beta (5Y Monthly) | 0.847 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.83 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 30.22 USD |
PRCT Valuation Measures
| Enterprise Value | 1.03B USD |
| Trailing P/E | N/A |
| Forward P/E | -23.129332 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 3.5403712 |
| Price/Book (mrq) | 3.2782323 |
| Enterprise Value/Revenue | 3.202 |
| Enterprise Value/EBITDA | -10.071 |
Trading Information
PROCEPT BioRobotics Stock Price History
| Beta (5Y Monthly) | 0.847 |
| 52-Week Change | -64.26% |
| S&P500 52-Week Change | 22.66% |
| 52 Week High | 62.17 USD |
| 52 Week Low | 19.35 USD |
| 50-Day Moving Average | 25.54 USD |
| 200-Day Moving Average | 29.93 USD |
PRCT Share Statistics
| Avg. Volume (3 month) | 1.48M USD |
| Avg. Daily Volume (10-Days) | 1.99M USD |
| Shares Outstanding | 56.92M |
| Float | 55.51M |
| Short Ratio | 4.11 |
| % Held by Insiders | 3.16% |
| % Held by Institutions | 102.38% |
| Shares Short | 6.78M |
| Short % of Float | 12.26% |
| Short % of Shares Outstanding | 11.91% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2025 |
| Most Recent Quarter (mrq) | March 31, 2026 |
| Next Fiscal Year End | December 31, 2026 |
Profitability
| Profit Margin | -31.82% |
| Operating Margin (ttm) | -39.22% |
| Gross Margin | 63.97% |
| EBITDA Margin | -31.79% |
Management Effectiveness
| Return on Assets (ttm) | -13.54% |
| Return on Equity (ttm) | -27.81% |
Income Statement
| Revenue (ttm) | 322.02M USD |
| Revenue Per Share (ttm) | 5.76 USD |
| Quarterly Revenue Growth (yoy) | 20.20% |
| Gross Profit (ttm) | 206.01M USD |
| EBITDA | -102377000 USD |
| Net Income Avi to Common (ttm) | -102473000 USD |
| Diluted EPS (ttm) | -1.83 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 245.64M USD |
| Total Cash Per Share (mrq) | 4.32 USD |
| Total Debt (mrq) | 78M USD |
| Total Debt/Equity (mrq) | 22.43 USD |
| Current Ratio (mrq) | 6.726 |
| Book Value Per Share (mrq) | 6.11 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -70132000 USD |
| Levered Free Cash Flow (ttm) | -43175248 USD |
Profile of PROCEPT BioRobotics
| Country | United States |
| State | CA |
| City | San Jose |
| Address | 150 Baytech Drive |
| ZIP | 95134 |
| Phone | 650 232 7200 |
| Website | https://www.procept-biorobotics.com |
| Industry | Medical Devices |
| Sector(s) | Healthcare |
| Full Time Employees | 888 |
PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology in the United States and internationally. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery focusing on treating benign prostatic hyperplasia. The company also provides HYDROS Robotic System, which provides Aquablation therapy image-guided robotic therapy to treat males suffering from lower urinary tract symptoms due to benign prostatic hyperplasia. PROCEPT BioRobotics Corporation was incorporated in 2007 and is headquartered in San Jose, California.
Q&A For PROCEPT BioRobotics Stock
What is a current PRCT stock price?
PROCEPT BioRobotics PRCT stock price today per share is 20.6 USD.
How to purchase PROCEPT BioRobotics stock?
You can buy PRCT shares on the Tech Market Middle exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for PROCEPT BioRobotics?
The stock symbol or ticker of PROCEPT BioRobotics is PRCT.
Which industry does the PROCEPT BioRobotics company belong to?
The PROCEPT BioRobotics industry is Medical Devices.
How many shares does PROCEPT BioRobotics have in circulation?
The max supply of PROCEPT BioRobotics shares is 56.92M.
What is PROCEPT BioRobotics Price to Earnings Ratio (PE Ratio)?
PROCEPT BioRobotics PE Ratio is now.
What was PROCEPT BioRobotics earnings per share over the trailing 12 months (TTM)?
PROCEPT BioRobotics EPS is -1.83 USD over the trailing 12 months.
Which sector does the PROCEPT BioRobotics company belong to?
The PROCEPT BioRobotics sector is Healthcare.
PROCEPT BioRobotics PRCT included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
|
|
{{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
US Tech Composite
IXIC
US
|
25587.04 USD — |
-2.21
|
13.85B USD — | 25513.26 USD — | 25882.57 USD — | — - | 13.85B USD — |
|
US Tech US 700 Small Cap Index
NQUS700SC
US
|
3090.39 USD — |
-0.26
|
— — | 3063.94 USD — | 3108.39 USD — | — - | — — |
|
US Tech AlphaDEX Multi Cap Growt
NQDXUSMLTCG
US
|
4123.39 USD — |
-2.34
|
— — | 4089.8 USD — | 4163.55 USD — | — - | — — |
|
US Tech Health Care
IXHC
US
|
1184.66 USD — |
+0.75
|
— — | 1174.72 USD — | 1192.68 USD — | — - | — — |
|
US Tech Global Market Composite
NQGM
US
|
2310.38 USD — |
-1.07
|
— — | 2287.99 USD — | 2333.46 USD — | — - | — — |
- {{ link.label }} {{link}}